234 related articles for article (PubMed ID: 2583862)
1. Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.
Koretz K; Moldenhauer G; Majdic O; Möller P
Int J Cancer; 1989 Nov; 44(5):816-22. PubMed ID: 2583862
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
4. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
Momburg F; Koretz K; Von Herbay A; Möller P
Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
Möller P; Mattfeldt T; Gross C; Schlosshauer P; Koch A; Koretz K; Moldenhauer G; Kaufmann M; Otto HF
Am J Pathol; 1989 Jul; 135(1):73-83. PubMed ID: 2549795
[TBL] [Abstract][Full Text] [Related]
6. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
Momburg F; Herrmann B; Moldenhauer G; Möller P
Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
[TBL] [Abstract][Full Text] [Related]
7. Expression of HLA-D sub-region products on human colorectal carcinoma.
Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
9. [Detection of HLA-DR, DQ and DP loci on monocytes using monoclonal antibodies].
Májský A
Cas Lek Cesk; 1987 Oct; 126(42):1313-6. PubMed ID: 3677160
[No Abstract] [Full Text] [Related]
10. Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognois.
Brunner CA; Gokel JM; Riethmüller ; Johnson JP
Eur J Cancer; 1991; 27(4):411-6. PubMed ID: 1828168
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
Niedecken H; Lutz G; Bauer R; Kreysel HW
J Am Acad Dermatol; 1988 Dec; 19(6):1030-7. PubMed ID: 2462575
[TBL] [Abstract][Full Text] [Related]
12. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
13. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis.
Müller CA; Markovic-Lipkovski J; Risler T; Bohle A; Müller GA
Kidney Int; 1989 Jan; 35(1):116-24. PubMed ID: 2468811
[TBL] [Abstract][Full Text] [Related]
14. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
[TBL] [Abstract][Full Text] [Related]
15. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA class II determinants by normal and chronic myeloid leukemia progenitors.
Piacibello W; Aglietta M; Stacchini A; Spinelli P; Salvetti L; Kerim S; Malavasi F; Infelise V; Resegotti L; Gavosto F
Leuk Res; 1987; 11(3):285-90. PubMed ID: 3470577
[TBL] [Abstract][Full Text] [Related]
17. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease.
Marley NJ; Macartney JC; Ciclitira PJ
Clin Exp Immunol; 1987 Nov; 70(2):386-93. PubMed ID: 3322617
[TBL] [Abstract][Full Text] [Related]
19. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
Haslam PL; Parker DJ; Townsend PJ
Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet B-induced loss of HLA class II antigen expression on lymphocytes is dose, time, and locus dependent.
Deeg HJ; Sigaroudinia M
Exp Hematol; 1990 Sep; 18(8):916-9. PubMed ID: 2387342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
